Los Angeles Capital Management LLC Replimune Group, Inc. Transaction History
Los Angeles Capital Management LLC
- $28.5 Billion
- Q3 2025
A detailed history of Los Angeles Capital Management LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 42,774 shares of REPL stock, worth $382,827. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,774
Previous 43,422
1.49%
Holding current value
$382,827
Previous $403,000
55.58%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding REPL
# of Institutions
195Shares Held
77.5MCall Options Held
2.06MPut Options Held
2.86M-
Baker Bros. Advisors LP New York, NY11MShares$98.9 Million1.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$96.8 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$42.2 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.66MShares$41.7 Million5.27% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$35 Million9.84% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $441M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...